Rasmussen encephalitis is a rare and progressive neurological condition that causes ongoing inflammation in one half of the brain, leading to frequent seizures and gradual loss of neurological function. This challenging disease primarily affects young children, though it can occasionally occur in teenagers and adults, bringing significant changes to their abilities and daily lives.

Epidemiology

Rasmussen encephalitis stands out as an exceptionally rare neurological disorder. According to research estimates, it affects approximately 2 out of every 10 million people worldwide^[1]. Another source suggests there may be between 200 and 500 cases identified globally^[5], highlighting just how uncommon this condition truly is. Large epilepsy centers typically identify no more than two new cases per year^[2], which means even experienced neurologists may encounter very few patients with this disease throughout their careers.

The condition predominantly affects children, with most cases appearing in youngsters between the ages of 2 and 10 years^[1]. The peak age range appears to be between 6 and 10 years old, with some sources noting that most cases are seen in children around six to seven years of age^[2]. Despite this strong childhood predominance, Rasmussen encephalitis does not exclusively target young patients. Approximately 10 percent of all diagnosed cases occur in adolescents and adults^[2], demonstrating that this condition can emerge at various life stages, though this remains the exception rather than the rule.

What makes the epidemiology of Rasmussen encephalitis particularly interesting is that it typically strikes previously healthy individuals without warning^[2]. There are no clear patterns related to gender, ethnicity, or geographic location that would help predict who might develop this condition. The disease appears to occur sporadically, affecting children who were developing normally before the onset of symptoms.

Causes

The underlying cause of Rasmussen encephalitis remains one of medicine’s puzzles, and scientists continue to investigate why this condition develops. However, researchers have developed two main theories that may explain how this disease begins, though neither has been definitively proven^[1].

The first theory suggests that Rasmussen encephalitis is an autoimmune disease, which is a condition where the body’s immune system mistakenly attacks its own healthy tissues^[1]. In a normally functioning immune system, specialized cells and proteins work together to identify and eliminate foreign invaders like bacteria and viruses. However, in autoimmune conditions, this protective system becomes confused and begins targeting the body’s own cells as if they were dangerous intruders. In the case of Rasmussen encephalitis, researchers believe the immune system may be attacking healthy brain tissue in one hemisphere for reasons that are not yet understood.

Scientific evidence increasingly supports this autoimmune theory. Studies examining affected brain tissue have found infiltration of specific immune cells called cytotoxic CD8+ T lymphocytes, which are white blood cells that normally destroy infected cells^[4]. These T cells appear to be attacking neurons (brain cells) and astrocytes (support cells in the brain), releasing destructive proteins that cause cell death. The presence of activated microglia, which are the brain’s resident immune cells, has also been observed in affected brain tissue, indicating an ongoing inflammatory response^[4].

The second theory proposes that Rasmussen encephalitis might result from an unknown virus entering the brain^[1]. Some researchers have suggested that common viruses such as influenza, measles, or cytomegalovirus (a common virus that can cause serious illness in people with weakened immune systems) might trigger the condition^[5]. The idea is that a viral infection could either directly damage brain tissue or trigger an abnormal immune response that continues long after the virus itself is gone. However, despite careful examination of affected brain tissue, researchers have not been able to identify a specific virus that consistently causes the disease^[1], which makes this theory harder to prove.

Risk Factors

Unlike many other medical conditions, Rasmussen encephalitis does not have clearly identifiable risk factors that would help predict who might develop the disease. The condition appears to strike randomly among the population, affecting previously healthy children without any obvious predisposing factors^[2].

Age represents the only consistent pattern observed in patients with Rasmussen encephalitis. Being a child between 2 and 10 years old is the primary demographic characteristic associated with the disease, though this is more of an observation than a true risk factor. The condition does not show a preference for one gender over another, and it affects children across all ethnic backgrounds and geographic regions equally.

There are no known lifestyle factors, environmental exposures, dietary habits, or behaviors that increase the likelihood of developing Rasmussen encephalitis. The disease does not appear to be linked to previous head injuries, other medical conditions, or family history of neurological disorders. This lack of identifiable risk factors makes the condition particularly difficult to predict or prevent, and it means that parents and children cannot take specific steps to reduce their risk of developing this disease.

Symptoms

The symptoms of Rasmussen encephalitis typically develop gradually and worsen over time, following a progressive pattern that can be devastating for affected children and their families. Understanding these symptoms and how they evolve is important for early recognition and appropriate medical care.

The first sign of Rasmussen encephalitis is typically a seizure, which is an episode of abnormal electrical activity in the brain that causes changes in behavior, movements, feelings, or levels of consciousness^[1]. These initial seizures can take several different forms. Some children experience generalized tonic-clonic seizures, which cause strong muscle movements on both sides of the body, including convulsions^[1]. Others have focal aware seizures, where the child remains conscious and aware but may experience symptoms like twitching of one hand or arm. A third type is focal impaired awareness seizures, which begin in one side of the brain and cause changes in the child’s level of consciousness during some or all of the episode^[1].

Another common early symptom is mild weakness in a child’s arm or leg^[1]. Parents might notice that their child has difficulty with activities that require coordination or strength on one side of the body, though this weakness is often subtle at first and may be mistaken for clumsiness or fatigue.

As the disease progresses, the seizures typically become more frequent and severe. About half of people with Rasmussen encephalitis develop a particularly challenging type of seizure called epilepsia partialis continua, which involves continuous twitching of the face, arm, or leg on one side of the body^[2]. These seizures may occur every few seconds or minutes^[1], creating an exhausting and distressing situation for both the child and family. The seizures are also intractable, which means they do not respond well to anti-seizure medications^[1], making them particularly difficult to control with standard treatments.

Within a few months to a couple of years after the first seizure, additional symptoms typically emerge^[1]. Mental decline becomes apparent, with children experiencing problems with thinking, memory, and learning abilities. Parents and teachers may notice that a child who was previously doing well in school begins to struggle with academic tasks, shows difficulty concentrating, or has trouble remembering information they previously knew.

Progressive loss of motor skills on one side of the body, called hemiparesis, is another characteristic symptom^[2]. This weakness affects the opposite side of the body from where the brain inflammation is occurring, due to the way the nervous system is wired. Over time, this weakness often advances to complete paralysis on one side of the body, known as hemiplegia^[1]. Children may lose the ability to walk independently or use one of their hands for daily activities.

If Rasmussen encephalitis affects the side of the brain that controls language functions (usually the left hemisphere), children develop progressive loss of speech and language abilities, called aphasia^[1]. This can be particularly devastating, as children may lose the ability to express themselves verbally or understand what others are saying to them. The extent of language problems depends heavily on which hemisphere is affected, with language and thinking disturbances almost always present when the left side of the brain is involved^[2].

Many children also experience partial loss of vision in half of their visual field, a condition called hemianopsia^[1]. This means they cannot see objects in either the right or left half of their vision in both eyes^[2]. Additional symptoms may include difficulty speaking clearly (dysarthria), problems with swallowing (dysphagia), sensory changes, and even psychiatric problems^[2].

For most people with Rasmussen encephalitis, the disease is most severe during the first eight to 12 months after symptoms begin^[1]. During this acute phase, the inflammation is most active and symptoms worsen progressively. After this period, the progression of the condition typically slows or stops, though the neurological damage that has occurred is permanent^[1]. This means that while the active destruction may cease, children are left with lasting disabilities that require ongoing support and rehabilitation.

Prevention

Unfortunately, because the exact cause of Rasmussen encephalitis remains unknown and there are no identifiable risk factors, there are currently no known strategies to prevent the disease from developing. Unlike some conditions that can be prevented through vaccination, lifestyle modifications, or avoiding certain exposures, Rasmussen encephalitis appears to occur spontaneously without clear triggers that could be avoided.

Since the condition is believed to be either autoimmune in nature or possibly triggered by an unknown virus, general health practices that support immune system function are reasonable, though there is no evidence that these measures specifically prevent Rasmussen encephalitis. Ensuring children receive recommended vaccinations against common childhood illnesses may help prevent viral infections, though no specific virus has been definitively linked to the disease.

The most important aspect of managing Rasmussen encephalitis is early recognition and prompt medical attention. Parents should be aware that if their child experiences a seizure for the first time, it is crucial to see a healthcare provider as soon as possible^[1]. While most first-time seizures do not indicate Rasmussen encephalitis, early evaluation by a neurologist can help identify the condition sooner, which may lead to earlier intervention and potentially better outcomes.

For children who have been diagnosed with Rasmussen encephalitis, preventing complications and maximizing quality of life becomes the focus. This includes working closely with a multidisciplinary medical team, adhering to treatment recommendations, participating in rehabilitation programs, and providing supportive care to address the various challenges the disease presents. While these measures do not prevent the disease itself, they can help minimize the impact of symptoms and support the best possible functional outcomes for affected children.

Pathophysiology

Pathophysiology refers to the changes that occur in normal body functions when a disease is present. In Rasmussen encephalitis, these changes are primarily centered in the brain and result from ongoing inflammation that progressively damages brain tissue.

The hallmark feature of Rasmussen encephalitis is chronic, progressive inflammation that is typically limited to a single hemisphere of the brain^[4]. This means that while one half of the brain is being attacked by the inflammatory process, the other half generally remains unaffected. The inflammation usually begins in a specific area of the brain and then gradually spreads throughout the affected hemisphere^[2], causing increasing damage over time.

At the cellular level, the inflammation involves several types of immune cells and processes. The most significant finding is the infiltration of cytotoxic CD8+ T lymphocytes into brain tissue^[4]. These immune cells, which normally help fight infections by destroying virus-infected cells, instead target and attack healthy neurons and astrocytes in the brain. The T cells release destructive enzymes and proteins, including granzyme B and perforin, which punch holes in cell membranes and trigger cell death through a process called apoptosis^[4].

Activated microglia are also abundant in affected brain tissue. These resident immune cells of the brain become overactive and contribute to the inflammatory response, releasing various substances that further damage neurons and support cells. This creates a cycle of inflammation and cell death that continues even as individual immune cells are replaced with new ones^[4].

As the inflammation continues, it causes progressive cortical atrophy, which means the outer layer of the brain (the cortex) shrinks and loses volume. This atrophy is most pronounced in the frontal and insular lobes of the brain and tends to spread backward toward the posterior regions as the disease progresses^[4]. The destruction of brain tissue leads to gliosis, a process where support cells in the brain multiply to fill in spaces left by dead neurons, similar to how scar tissue forms in other parts of the body^[4].

The seizures that are so characteristic of Rasmussen encephalitis occur because the inflammation disrupts the normal electrical activity of the brain. Damaged neurons become hyperexcitable, meaning they fire electrical signals more easily and more frequently than normal. This abnormal electrical activity can spread through the affected hemisphere, causing the various types of seizures experienced by patients. The continuous nature of some seizures, particularly epilepsia partialis continua, reflects the ongoing electrical instability caused by the inflammatory damage.

The progressive loss of motor function, cognitive abilities, language skills, and vision that occurs in Rasmussen encephalitis directly results from the death of neurons in the specific regions of the brain responsible for these functions. Because the brain is organized with different regions controlling different abilities, the pattern of symptoms depends on exactly which areas are most affected by the inflammation. The wiring of the nervous system means that damage to one hemisphere of the brain affects the opposite side of the body, which is why weakness and paralysis occur on the side opposite to the inflamed hemisphere^[2].

The disease typically progresses through distinct stages. During the acute stage, which may last between four to eight months, the inflammation is most active and symptoms worsen rapidly^[4]. Brain imaging during this phase often reveals swelling of the affected hemisphere and the beginning signs of tissue loss. Following this acute period, the disease typically enters a chronic or residual stage where the active inflammation lessens but the structural damage to the brain remains^[4]. While the immune attack may diminish in intensity, patients are left with permanent neurological deficits due to the loss of brain tissue that occurred during the active phase.